Aug 7 (Reuters) -
Medical technology firm Heartflow said on Thursday it has
raised $316.67 million in its U.S. initial public offering.
The Mountain View, California-based company priced 16.67
million shares at $19 each, compared with its targeted range of
$17 and $18 apiece.